(Q42067876)

16 October 2017

title

Intentional massive insulin overdose: recognition and management (English)

1 reference

16 October 2017

1 reference

Roberge RJ

1

1 reference

16 October 2017

Martin TG

series ordinal

2

1 reference

16 October 2017

Delbridge TR

series ordinal

3

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

Annals of Emergency Medicine

16 October 2017

published in

1 reference

16 October 2017

volume

22

1 reference

16 October 2017

issue

2

1 reference

16 October 2017

page(s)

228-234

1 reference

Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Unusual problems for the physician in managing a hospital patient who received a malicious insulin overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Incidence of severe hypoglycemia and its causes in insulin-treated diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Severe hypoglycemia in diabetic patients: frequency, causes, prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Serum glucose changes after administration of 50% dextrose solution: pre- and in-hospital calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

A direct assay for proinsulin in plasma and its applications in hypoglycaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Massive insulin overdose: detailed studies of free insulin levels and glucose requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Local excision of subcutaneous fat in the management of insulin overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Managing suicidal insulin overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Transient hepatomegaly and hypoglycemia. A consequence of malicious insulin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Excessive insulin therapy: biochemical effects and clinical repercussions. Current concepts of counterregulation in type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Absorption of isophane (NPH) insulin and its clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Role of the kidney in insulin metabolism and excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

An unusual case of insulin overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Attempted suicide by insulin injection treated with artificial pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Mechanisms of insulin resistance in man. Assessment using the insulin dose-response curve in conjunction with insulin-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Esophageal food impaction: treatment with glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Electrophysiological effects of glucagon on the normal canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Systemic and coronary hemodynamic effects of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Suicidal insulin overdose managed by excision of insulin injection site.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Closed-loop and Open-loop Devices for Blood Glucose Control in Normal and Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

Serum glucose after intraperitoneal infusion of 5% dextrose solution

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980210-0

7 January 2021

10.1016/S0196-0644(05)80210-0

Identifiers

DOI

1 reference

16 October 2017

1 reference